InvestorsHub Logo
Followers 34
Posts 1982
Boards Moderated 0
Alias Born 01/25/2010

Re: Bones58gdi post# 18572

Monday, 01/02/2012 4:40:26 PM

Monday, January 02, 2012 4:40:26 PM

Post# of 333418
There are people out there who don't use common sense, so if they hurt themselves with a chainsaw, they are ready to sue the chainsaw manufacturer. So that is why there has to be warning labels attached to the chainsaws.

We have a governing body over the use of chemicals and medical devices to make sure the necessary safeguards are in place since those products are meant to be used on/in our bodies. If not, some of these manufacturers may get a little sloppy with how they test and manufacture these products in their goal to make money. As in any situation, the abuse by a few can negatively impact many. At the end of the day, it is a business. The by-product of such sloppiness directly results in someone being seriously hurt or killed. The problem is that no one can fully understand the long-term effects of these products until they start happening sometimes. Since the reaction of a product can vary by the person, you can't really get a full idea of how someone may react to a product. It would be difficult to ask a company to test a product on millions of people over decades as opposed to thousands for a few years. I've read that the only reason we have an expiration date on OTC medicine (ie. pain relievers) is because that is the period in which the medicine was tested. What may happen after the expiration date is not fully known. An example of questionable test results was posted in the FDA reviewer article I posted. I follow a few biotech analysts, and they are raising similar concerns regularly when companies release their test data.

As I've stated before, I've invested in a company where the CEO was making claims that his product would help so many people and he was frustrated with the FDA not clearing it for years. What he neglected to say to investors(for a short period of time) is that the FDA had specific concerns that weren't being addressed by the company that could affect consumer health.

While the overall process can be criticized, to criticize the individuals that execute the process is a bit unfair. Especially by internet professionals that I see on these messageboards sometimes. As it was shown in the interview I posted, they can be caught in a difficult position.

My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.